Clinical Trial Update: Effect of Dapagliflozin Administration on the Apoptosis Levels of Patients With Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

A Phase 4 study examined whether dapagliflozin affects apoptosis levels in patients with acute myocardial infarction, including STEMI and NSTEMI. The trial has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Non-st-elevation Myocardial Infarction
• St-elevation Myocardial Infarction

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Yoga Yudhistira | Conditions: Acute Myocardial Infarction (AMI), STEMI - ST Elevation Myocardial Infarction (MI) | Phase 4 | Status: COMPLETED